2nd Quarter - Report
CURA STRATEGIES for PKD FOUNDATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Firm
Client
Income
$10,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 22, 2025 | $10,000 | Replaced |
| 2nd Quarter - Amendment | Jul 31, 2026 | $10,000 | Replaced |
| 2nd Quarter - Amendment | Jul 31, 2026 | $10,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Federal funding for PKD research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
| SYDNEY SHEPHERD | — |
Health Issues HCR
Policies to encourage organ donation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
| SYDNEY SHEPHERD | — |
Defense DEF
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT C LEEZER | Aide to Senator Dick Durbin (D-IL) |
| PATRICK MEADE New | — |
| SYDNEY SHEPHERD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.